11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Adaptimmune Therapeutics plc (ADAP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

0.9767

+0.0783

(+8.72%)

At close: 04:00PM EDT

0.9839

+0.01

(+0.74%)

After hours:

07:41PM EDT

Currency in USD

Earnings estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	4	5	4	5
Avg. Estimate	-0.1	-0.06	-0.28	-0.42
Low estimate	-0.17	-0.14	-0.55	-0.7
High estimate	-0.03	-0.01	-0.06	-0.06
Year ago EPS	0.01	-0.12	-0.54	-0.28

Revenue estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	6	7	6	7
Avg. Estimate	4.07M	21.62M	63.79M	56.75M
Low estimate	N/A	4.4M	22.2M	21.5M
High estimate	15M	38M	92.96M	90.7M
Year ago sales	47.6M	5.13M	60.28M	63.79M
Sales growth (year/est)	-91.40%	321.40%	5.80%	-11.00%

Earnings history	30/03/2023	29/06/2023	29/09/2023	30/12/2023
Est. EPS	-0.14	-0.13	-0.12	-0.1
Actual EPS	0.01	-0.12	-0.2	-0.24
Difference	0.15	0.01	-0.08	-0.14
Surprise %	107.10%	7.70%	-66.70%	-140.00%

EPS trend	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Current estimate	-0.1	-0.06	-0.28	-0.42
7 days ago	-0.1	-0.06	-0.27	-0.37
30 days ago	-0.1	-0.06	-0.27	-0.37
60 days ago	-0.14	-0.14	-0.49	-0.61
90 days ago	-0.14	-0.14	-0.49	-0.61

EPS revisions	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Up last 7 days	N/A	N/A	N/A	N/A
Up last 30 days	1	1	1	N/A
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	1	1	1	1

Growth estimates	ADAP	Industry	Sector(s)	S&P 500
Current qtr.	-1,100.00%	N/A	N/A	N/A
Next qtr.	50.00%	N/A	N/A	N/A
Current year	48.10%	N/A	N/A	N/A
Next year	-50.00%	N/A	N/A	N/A
Next 5 years (per annum)	1.00%	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A